Short answer
Integrate external knowledge and collaboration into the innovation pipeline to enhance competitiveness and adapt to industry shifts.
- Field
- Innovation & Markets
- Source
- Gothenburg University Publications Electronic Archive (Gothenburg University) (2012)
- Method
- Case Study
- Evidence
- Strong effect
Adopting open innovation strategies is crucial for pharmaceutical companies to remain competitive in a rapidly evolving industry. This innovation & markets research insight is drawn from a 2012 study published in Gothenburg University Publications Electronic Archive (Gothenburg University). Using Case study, researchers explored how this design variable affects real-world outcomes. The key design takeaway: Integrate external knowledge and collaboration into the innovation pipeline to enhance competitiveness and adapt to industry shifts.
Open Innovation Strategies Drive Pharmaceutical Competitiveness
Adopting open innovation strategies is crucial for pharmaceutical companies to remain competitive in a rapidly evolving industry.
Gothenburg University Publications Electronic Archive (Gothenburg University) · 2012
Key Findings
- 01The pharmaceutical industry is undergoing significant change, necessitating new innovation approaches.
- 02Both AstraZeneca and Eli Lilly are exploring different open innovation strategies to maintain competitiveness.
- 03Openness in innovation development is imperative for staying competitive in the pharmaceutical sector.
Application
Design takeaway
Integrate external knowledge and collaboration into the innovation pipeline to enhance competitiveness and adapt to industry shifts.
How to apply
When developing new products or services, actively seek opportunities for collaboration with external entities, research institutions, or even competitors, while carefully managing intellectual property agreements.
Project actions
- 01Consider how your design project could benefit from or contribute to external collaborations.
- 02Research existing partnerships or open innovation models within your chosen design field.
Method & Evidence
Variables
Strengths & Limitations
Strengths
- +Focuses on a critical aspect of modern business strategy.
- +Provides insights from real-world industry examples.
Limitations
The specific open innovation strategies and their effectiveness can vary greatly between companies and industries.
Reliability & validity
The case study method relies on the interpretation of available data and may be subject to researcher bias. The findings' generalizability is limited by the small sample size.
Think critically
To what extent can intellectual property concerns hinder the effectiveness of open innovation in highly regulated industries?
Design Principles
"Embrace collaborative innovation to foster agility and competitiveness."
This research highlights that traditional, closed innovation models are becoming insufficient in the pharmaceutical sector. By engaging with external partners and knowledge, companies can accelerate the development of new treatments and stay ahead of market demands.
What This Means for Your Design
Companies in the pharmaceutical industry need to work with others outside their company to create new medicines and treatments, or they won't be able to compete.
How to use in your project
- 1.Reference this study when discussing the strategic importance of collaboration in your design process.
- 2.Use it to justify exploring external partnerships for your design project.
Add to My Project
Quick Cite
Paragraph starter
The pharmaceutical industry's competitive landscape necessitates the adoption of open innovation strategies, as demonstrated by companies like AstraZeneca and Eli Lilly. This approach, which involves collaborating with external entities, is crucial for accelerating innovation and maintaining market relevance in a rapidly evolving sector.
Source
Gothenburg University Publications Electronic Archive (Gothenburg University)
The Role of Open Innovation: Focus on the Pharmaceutical Industry
journal · 2012
View sourceQuestions About This Research
- What does the research say about open innovation strategies drive pharmaceutical competitiveness?
- Integrate external knowledge and collaboration into the innovation pipeline to enhance competitiveness and adapt to industry shifts. Evidence: Gothenburg University Publications Electronic Archive (Gothenburg University) (2012).
- Why does "Open Innovation Strategies Drive Pharmaceutical Competitiveness" matter for design?
- This research highlights that traditional, closed innovation models are becoming insufficient in the pharmaceutical sector. By engaging with external partners and knowledge, companies can accelerate the development of new treatments and stay ahead of market demands.
- How can designers apply this research?
- Integrate external knowledge and collaboration into the innovation pipeline to enhance competitiveness and adapt to industry shifts.
- What were the main findings?
- The pharmaceutical industry is undergoing significant change, necessitating new innovation approaches.. Both AstraZeneca and Eli Lilly are exploring different open innovation strategies to maintain competitiveness.. Openness in innovation development is imperative for staying competitive in the pharmaceutical sector.
- What research method was used?
- Case Study.
- How strong is the evidence?
- Evidence strength is rated Strong effect, based on a 2012 journal from Gothenburg University Publications Electronic Archive (Gothenburg University).
- What should I do differently in my next project?
- When developing new products or services, actively seek opportunities for collaboration with external entities, research institutions, or even competitors, while carefully managing intellectual property agreements.
- What are the limitations?
- The study focuses on two specific companies, and findings may not be universally applicable across the entire pharmaceutical industry.